Related Experiment Video
Updated: Mar 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TGR5 activation suppressed S1P/S1P2 signaling and resisted high glucose-induced fibrosis in glomerular mesangial
Zhiying Yang1, Fengxiao Xiong2, Yu Wang2
1Laboratory of Pharmacology & Toxicology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China; National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangzhou 510006, China; Guangdong Provincial Engineering Laboratory of Druggability and New Drugs Evaluation, Guangzhou 510006, China.
Abstract:
Glucose and lipid metabolism disorders and chronic inflammation in the kidney tissues are largely responsible for causative pathological mechanism of renal fibrosis in diabetic nephropathy (DN). As our previous findings confirmed that, sphingosine 1-phosphate (S1P)/sphingosine 1-phosphate receptor 2 (S1P2) signaling activation promoted renal fibrosis in diabetes. Numerous studies have demonstrated that the G protein-coupled bile acid receptor TGR5 exhibits effective regulation of glucose and lipid metabolism and anti-inflammatory effects. TGR5 is highly expressed in kidney tissues, whether it attenuates the inflammation and renal fibrosis by inhibiting the S1P/S1P2 signaling pathway would be a new insight into the molecular mechanism of DN. Here we investigated the effects of TGR5 on diabetic renal fibrosis, and the underlying mechanism would be also discussed. We found that TGR5 activation significantly decreased the expression of intercellular adhesion molecule-1 (ICAM-1) and transforming growth factor-beta 1 (TGF-β1), as well as fibronectin (FN) induced by high glucose in glomerular mesangial cells (GMCs), which were pathological features of DN. S1P2 overexpression induced by high glucose was diminished after activation of TGR5, and AP-1 activity, including the phosphorylation of c-Jun/c-Fos and AP-1 transcription activity, was attenuated. As a G protein-coupled receptor, S1P2 interacted with TGR5 in GMCs. Furthermore, INT-777 lowered S1P2 expression and promoted S1P2 internalization. Taken together, TGR5 activation reduced ICAM-1, TGF-β1 and FN expressions induced by high glucose in GMCs, the mechanism might be through suppressing S1P/S1P2 signaling, thus ameliorating diabetic nephropathy.
Insights
Activating the TGR5 receptor reduces kidney fibrosis in diabetic nephropathy by inhibiting sphingosine 1-phosphate/sphingosine 1-phosphate receptor 2 (S1P/S1P2) signaling. This mechanism ameliorates inflammation and pathological markers in kidney cells.
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Diabetic nephropathy (DN) involves glucose/lipid metabolism disorders and kidney inflammation, leading to renal fibrosis.
- Previous research linked sphingosine 1-phosphate (S1P)/sphingosine 1-phosphate receptor 2 (S1P2) signaling activation to promoting renal fibrosis in diabetes.
- The G protein-coupled bile acid receptor TGR5 is known for regulating metabolism and possessing anti-inflammatory effects, with high expression in kidney tissues.
Purpose of the Study:
- To investigate the effects of TGR5 activation on diabetic renal fibrosis.
- To elucidate the underlying molecular mechanism, specifically whether TGR5 inhibits S1P/S1P2 signaling to attenuate DN.
- To explore TGR5's role in regulating inflammation and fibrosis markers in kidney cells.
Main Methods:
- Investigated the impact of TGR5 activation on high glucose-induced expression of intercellular adhesion molecule-1 (ICAM-1), transforming growth factor-beta 1 (TGF-β1), and fibronectin (FN) in glomerular mesangial cells (GMCs).
- Assessed the effect of TGR5 activation on high glucose-induced S1P2 overexpression and AP-1 activity (including c-Jun/c-Fos phosphorylation).
- Examined the interaction between S1P2 and TGR5 in GMCs and the effect of INT-777 (a TGR5 activator) on S1P2 expression and internalization.
Main Results:
- TGR5 activation significantly decreased high glucose-induced ICAM-1, TGF-β1, and fibronectin expression in GMCs.
- Activation of TGR5 diminished high glucose-induced S1P2 overexpression and attenuated AP-1 activity.
- S1P2 was found to interact with TGR5 in GMCs, and INT-777 treatment reduced S1P2 expression and promoted its internalization.
Conclusions:
- TGR5 activation ameliorates diabetic nephropathy by reducing key pathological markers like ICAM-1, TGF-β1, and fibronectin in kidney cells.
- The mechanism involves the suppression of the S1P/S1P2 signaling pathway.
- Targeting TGR5 represents a potential therapeutic strategy for managing diabetic nephropathy.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
GPCR Desensitization
cAMP-dependent Protein Kinase Pathways
Activation and Inactivation of G Proteins

